Online edition of India's National Newspaper
Tuesday, Feb 24, 2009
ePaper | Mobile/PDA Version
Google



Opinion
News: ePaper | Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous | Engagements |
Advts:
Retail Plus | Classifieds | Jobs | Obituary |

Opinion - News Analysis Printer Friendly Page   Send this Article to a Friend

India protects remedies from foreign patents

Randeep Ramesh

Trend towards ‘bio-prospecting’ identified; 200,000 treatments licensed for free public use.

In the first step by a developing country to stop multinational companies patenting traditional remedies from local plants and animals, the Indian government has effectively licensed 200,000 local treatments as “public property” free for anyone to use but no one to sell as a “brand”.

The move comes after scientists in Delhi noticed an alarming trend — the “bio-prospecting” of natural remedies by companies abroad. After trawling through the records of the global trademark offices, officials found 5,000 patents had been issued — at a cost of at least $150m — for “medical plants and traditional systems.”

“More than 2,000 of these belong to the Indian systems of medicine ... We began to ask why multinational companies were spending millions of dollars to patent treatments that so many lobbies in Europe deny work at all,” said Dr. Vinod Kumar Gupta, who heads the Traditional Knowledge Digital Library, which lists in encyclopaedic detail the 200,000 treatments. The database, which took 200 researchers eight years to compile by meticulously translating ancient Indian texts, will now be used by the European Patent Office to check against “bio-prospectors.”

Mr. Gupta points out that in Brussels alone there had been 285 patents for medicinal plants whose uses had long been known in the three principal Indian systems: ayurveda, India’s traditional medical treatment; unani, a system believed to have come to India via ancient Greece; and siddha, one of India’s oldest health therapies, from the south.

Researchers found that in Europe one company had patented an Indian creeping plant known as Brahmi - Bacopa monnieri — for a memory enhancer. Another patent was awarded for aloe vera for its use as a mouth ulcer treatment.

“We have shown the authorities that ayurveda, unani and siddha medicinal uses were known in India. We would like the patents therefore lifted,” said Mr. Gupta.

In the past India has had to go to court to get patents revoked. Officials say that to lift patents from medicines created from turmeric and neem, an Indian tree, it spent more than $5m. In the case of the neem patent, the legal battle took almost 10 years.

“We won because we proved these were part of traditional Indian knowledge. There was no innovation and therefore no patent should be granted,” said Mr. Gupta.

Yoga, too, is considered a traditional medicine and one that is already a billion-dollar industry in the US. Gupta said the Indian government had already asked the U.S. to register yoga as a “well-known” mark and raised concerns over the 130 yoga-related patents issued.

“We want no one to appropriate the yoga brand for themselves. There are 1,500 asanas [yogic poses] and exercises given in our ancient texts. We are transcribing these so they too cannot be appropriated by anyone.

“We have had instances where people have patented a yoga technique by describing a certain temperature. This is simply wrong.”

India is also unusual in that it has seven national medical systems — of which modern medicine is but one. Almost four-fifths of India’s billion people use traditional medicine and there are 430,000 ayurvedic medical practitioners registered by the government in the country. The department overseeing the traditional medical industry, known as Ayush, has a budget of 10 billion rupees .

India’s battle to protect its traditional treatments is rooted in the belief that the developing world’s rich biodiversity is a potential treasure trove of starting material for new drugs and crops. Mr. Gupta said that it costs the west $15b and 15 years to produce a “blockbuster drug.” A patent lasts for 20 years, so a pharmaceutical company has just five years to recover its costs — which makes conventional treatments expensive.

“If you can take a natural remedy and isolate the active ingredient then you just need drug trials and the marketing. traditional medicine could herald a new age of cheap drugs.” — © Guardian Newspapers Limited, 2009

Printer friendly page  
Send this article to Friends by E-Mail



Opinion

News: ePaper | Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous | Engagements |
Advts:
Retail Plus | Classifieds | Jobs | Obituary | Updates: Breaking News |


News Update


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | Publications | eBooks | Images | Ergo | Home |

Copyright © 2009, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu